"Диагностируем и лечим пациентов с заболеваниями нервной системы. Принимаем детей и взрослых, помогаем в самых тяжелых случаях. Принимаем пациентов со всей Украины. Институт неврологии, наркологии и психиатрии — это крупнейшая психоневрологическая клиника Украины и ведущий лечебно-диагностический центр страны. У нас можно получить консультацию специалиста, пройти обследование, амбулаторное или стационарное лечение и курс реабилитации. Если вам нужна консультация невролога, прием психотерапевта или психиатрическая помощт, вы можете обратиться в ИНПН."

During the past decade, Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 8 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "ACADIA Pharmaceuticals Inc." with 3 trials sponsored, "GlaxoSmithKline" with 2 trials sponsored, "Karuna Therapeutics" with 2 trials sponsored and "Sunovion" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology" #1 collaborator was "Bausch Health Americas, Inc." with 1 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology" are "Schizophrenia" (4 trials), "Epilepsy" (3 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials) and "Bipolar I Disorder" (1 trials). Many other conditions were trialed in "Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology" in a lesser frequency.

Most popular intervention types in "Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology" are "Drug" (19 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ocrelizumab" (5 trials), "Pimavanserin" (3 trials), "Fenebrutinib" (2 trials) and "Xanomeline and Trospium Chloride Capsules" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology has several departments that took part in Clinical trials: "SI Institute of Children and Adolescents Healthcare of NAMSU" - 3 trials